|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.32 CHF | +1.97% |
|
+4.94% | +8.78% |
| May. 10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
| May. 10 | Novartis Gets FDA Breakthrough Therapy Designation for Scemblix | DJ |
(MORE TO FOLLOW) Dow Jones Newswires
June 30, 2022 04:00 ET (08:00 GMT)
| 1st Jan change | Capi. | |
|---|---|---|
| +8.78% | 208B | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| -7.93% | 200B | |
| +7.68% | 166B | |
| -2.71% | 159B |
NOVARTIS AG 
